Sign In
Buy XGN
$4.54
-0.280 (-5.81%)
At Close: Jun 03, 2026
Exagen Inc. To Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
04:05pm, Wednesday, 03'rd Feb 2021
SAN DIEGO, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading autoimmune organization, today announced its participation in the BTIG MedTech, Digital Health, Life Science & Diagn
SAN DIEGO, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today
Exagen Inc. Reports Preliminary Fourth Quarter 2020 Testing Results
06:00pm, Sunday, 10'th Jan 2021
Record Testing Revenue, Adopters and AVISE CTD® Volumes
Exagen Inc. To Participate in 2021 ICR Conference
04:05pm, Tuesday, 05'th Jan 2021
SAN DIEGO, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today
SAN DIEGO, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today
Exagen (XGN) Looks Good: Stock Adds 9.3% in Session
09:11am, Monday, 04'th Jan 2021
Exagen (XGN) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.
Exagen Inc. to Participate in December Investor Conferences
04:05pm, Wednesday, 18'th Nov 2020
SAN DIEGO, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today
Exagen and GSK partner for 4th straight year, driving greater awareness of challenges facing lupus diagnosis and management
08:25am, Monday, 16'th Nov 2020
SAN DIEGO, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune dis
Exagen Inc. (XGN) CEO Ron Rocca on Q3 2020 Results - Earnings Call Transcript
09:03pm, Tuesday, 10'th Nov 2020
Exagen Inc. (XGN) CEO Ron Rocca on Q3 2020 Results - Earnings Call Transcript
Exagen Inc. Reports Third Quarter 2020 Results
04:05pm, Tuesday, 10'th Nov 2020
Record Adopters with 99% Stickiness and 14 Million In-Network Lives Added for AVISE® Testing Record Adopters with 99% Stickiness and 14 Million In-Network Lives Added for AVISE® Testing
Exagen Inc. To Participate in November Investor Conferences
08:25am, Monday, 09'th Nov 2020
SAN DIEGO, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today
Exagen Inc. Announces Study to Evaluate Emergence of Autoimmune Diseases After COVID-19 Infection
08:25am, Monday, 02'nd Nov 2020
SAN DIEGO, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today
Exagen to Announce Third Quarter Financial Results on November 10, 2020
04:05pm, Tuesday, 27'th Oct 2020
SAN DIEGO, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced
